Search Results - "Mamusa, E."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Walking improvements with nabiximols in patients with multiple sclerosis by Coghe, G., Pau, M., Corona, F., Frau, J., Lorefice, L., Fenu, G., Spinicci, G., Mamusa, E., Musu, L., Massole, S., Massa, R., Marrosu, M. G., Cocco, E.

    Published in Journal of neurology (01-11-2015)
    “…Recently, nabiximols was approved as a treatment in MS spasticity. Data leading to approval and clinical use of nabiximols, although widely recognised, are…”
    Get full text
    Journal Article
  2. 2

    Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation by Capobianco, Marco, Motuzova, Y., Frau, J., Cocco, E., Mamusa, E., Marrosu, M. G., Bertolotto, A.

    Published in Neurological sciences (01-08-2012)
    “…High-dose cyclophosphamide followed by autologous haematopoietic stem cell transplantation (HDC-AHSCT) is a treatment option for aggressive and refractory…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population by Cocco, E, Sardu, C, Murru, R, Frau, J, Lorefice, L, Mamusa, E, Contu, P, Marrosu, MG

    Published in Multiple sclerosis (01-09-2009)
    “…Background The island of Sardinia features a high incidence of multiple sclerosis (MS) characterized by early age at onset and a progressively increasing…”
    Get full text
    Journal Article
  5. 5

    Factors influencing MS outcome in Sardinia: a clinical and genetic study by Cocco, E, Sardu, C, Piras, R, Mamusa, E, Coghe, G C, Fenu, G, Frau, J, Lorefice, L, Murru, R, Cucca, F, Marrosu, MGG

    Published in Multiple sclerosis (01-09-2008)
    “…Background: A wide variety of therapies aimed at preventing permanent disability are currently available for the treatment of multiple sclerosis (MS)…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8